Docoh
Loading...

MDRX Allscripts Healthcare Solutions

Allscripts is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Its innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Company profile

Ticker
MDRX
Exchange
CEO
Paul Black
Employees
Incorporated
Location
Fiscal year end
Former names
ALLSCRIPTS HEALTHCARE SOLUTIONS INC, ALLSCRIPTS HOLDING INC, ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC.
SEC CIK
Subsidiaries
Allscripts Holdings, LLC • Allscripts Holdings • Coniston Exchange, LLC • Allscripts Healthcare US, LP • Allscripts Healthcare, LLC • Allscripts Managed Services, LLC • Allscripts Software, LLC • California Healthcare Medical Billing, LLC • Allscripts Analytics, LLC • Allscripts Next, LLC ...
IRS number
364372754

MDRX stock data

(
)

Calendar

6 Aug 21
21 Oct 21
31 Dec 21
Quarter (USD)
Jun 21 Mar 21 Dec 20 Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 231.38M 231.38M 231.38M 231.38M 231.38M 231.38M
Cash burn (monthly) 94.71M (positive/no burn) (positive/no burn) 4.62M 66.98M 26.83M
Cash used (since last report) 351.29M n/a n/a 17.12M 248.43M 99.53M
Cash remaining -119.9M n/a n/a 214.26M -17.05M 131.85M
Runway (months of cash) -1.3 n/a n/a 46.4 -0.3 4.9

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
9 Sep 21 Paul Black Common Stock Sell Dispose S No Yes 14.5206 60,000 871.24K 1,500,386
7 Sep 21 Garrison Greg Common Stock Sell Dispose S No No 15.0234 77,381 1.16M 47,813
3 Sep 21 Tejal Vakharia Common Stock Payment of exercise Dispose F No No 15.2 1,223 18.59K 230,389
17 Aug 21 Richard J. Poulton Common Stock Sell Dispose S No Yes 16.694 10,000 166.94K 588,980
16 Aug 21 Richard J. Poulton Common Stock Sell Dispose S No Yes 16.936 10,000 169.36K 598,980
5 Aug 21 Lisa Khorey Common Stock Sell Dispose S No Yes 17.1412 3,000 51.42K 166,308
5 Aug 21 Lisa Khorey Common Stock Sell Dispose S No Yes 17.1404 47,000 805.6K 169,308

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 229 231 -0.9%
Opened positions 24 45 -46.7%
Closed positions 26 28 -7.1%
Increased positions 62 52 +19.2%
Reduced positions 98 93 +5.4%
13F shares
Current Prev Q Change
Total value 2.37B 10.71B -77.9%
Total shares 128.14M 135.02M -5.1%
Total puts 531.8K 361.6K +47.1%
Total calls 238.7K 153.8K +55.2%
Total put/call ratio 2.2 2.4 -5.2%
Largest owners
Shares Value Change
BLK Blackrock 24.52M $453.93M -0.2%
Vanguard 14.98M $277.35M -5.9%
Dimensional Fund Advisors 11.01M $203.75M +0.0%
Fisher Asset Management 5.69M $105.36M -4.2%
Fuller & Thaler Asset Management 5.02M $92.93M -2.3%
Wellington Management 4.98M $92.13M -6.0%
D. E. Shaw & Co. 4.44M $82.12M -10.1%
STT State Street 4.4M $81.41M -3.3%
JPM JPMorgan Chase & Co. 3.64M $67.31M +23.7%
Arrowstreet Capital, Limited Partnership 3.19M $59.06M -8.0%
Largest transactions
Shares Bought/sold Change
Caas Capital Management 0 -1.04M EXIT
Vanguard 14.98M -945.92K -5.9%
Compagnie Lombard Odier SCmA 0 -839.52K EXIT
GS Goldman Sachs 3.01M +705.27K +30.6%
JPM JPMorgan Chase & Co. 3.64M +697.01K +23.7%
MS Morgan Stanley 679.74K -579.61K -46.0%
D. E. Shaw & Co. 4.44M -500.3K -10.1%
WFC Wells Fargo & Co. 277.79K -490.86K -63.9%
Loomis Sayles & Co L P 1.69M +465.44K +38.1%
Tamarack Advisers 450K -425K -48.6%

Financial report summary

?
Risks
  • The novel coronavirus (“COVID-19”) pandemic has adversely impacted and could continue to adversely impact the business, results of operations, financial condition, liquidity and cash flows of us and our clients.
  • Markets for our products and services are highly competitive and subject to rapid technological change, and we may be unable to compete effectively in these markets.
  • Consolidation in the healthcare industry could adversely impact our business, financial condition and operating results.
  • We are subject to a number of existing laws, regulations and industry initiatives, and we are susceptible to a changing regulatory environment.
  • Increased government involvement in healthcare could materially and adversely impact our business.
  • Changes in interoperability and other regulatory standards applicable to our software could require us to incur substantial additional development costs.
  • We could fail to maintain and expand our business with our existing clients or effectively transition our clients to newer products.
  • Our products or services could fail to perform properly due to errors or similar problems.
  • We could be subject to liability as a result of information security breaches, and clients could be deterred from using our products and services.
  • We have acquired and expect to acquire new companies, investments or technologies, which are subject to significant risks.
  • The realignment of our sales, services and support organizations could adversely affect client relationships and affect our future growth.
  • Our clients may not accept our products and services or may delay decisions whether to purchase our products and services.
  • It is difficult to predict the sales cycle and implementation schedule for our products and services.
  • Our future success depends upon our ability to grow, and if we are unable to manage our growth effectively, we may incur unexpected expenses and be unable to meet our clients’ requirements.
  • We may be unable to successfully introduce new products or services or fail to keep pace with advances in technology.
  • Our business depends in part on our ability to establish and maintain additional strategic relationships.
  • We may be unable to protect, and we may incur significant costs in enforcing, our intellectual property rights.
  • We could be impacted by unfavorable results of legal proceedings and claims, such as being found to have infringed on a third party’s intellectual property rights.
  • Our success depends on the continued service and availability of key personnel.
  • Our independent content and service providers may fail to perform adequately or comply with laws, regulations or contractual covenants.
  • We may be liable for use of content we provide.
  • Changes to the healthcare regulatory landscape could force us to reduce our prices.
  • Our failure to license and integrate third-party technologies could harm our business.
  • Our business is subject to the risks of global operations.
  • Our Board of Directors is authorized to issue preferred stock, and our certificate of incorporation, bylaws and debt instruments contain anti-takeover provisions.
  • Our stock price is subject to volatility.
  • Our quarterly operating results may vary.
  • Our indebtedness could adversely affect our financial condition and prevent us from fulfilling our obligations.
  • The accounting method for convertible debt securities that may be settled in cash, such as the Convertible Notes, could have a material effect on our reported financial results.
  • We could be subject to changes in our tax rates, the adoption of new United States or international tax legislation or exposure to additional tax liabilities.
  • Our failure to maintain proper and effective internal controls over financial reporting could impair our ability to produce accurate and timely financial statements.
  • We could suffer losses due to asset impairment charges.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: acuity, annum, broker, calendar, case, colloquially, constitute, copy, COVID, discharged, distribution, entirety, Exhibit, flat, Khorey, Lisa, nonrenewal, President, receipt, sequelae, shortfall, shortly, syndrome, text, vaccine, variability, Vice, volume, windfall, yielded
Removed: CODM, driven, international, mature, month, notional, reclassified, staggered, target, urgency

Patents

GRANT
Utility
Systems and methods for clinical task separation in electronic health record applications
19 Oct 21
A server EHR executing on a server computing device is in communication with a client EHR executing on a first client computing device, and receives a prescription authorization from the client EHR, the prescription authorization based on input received from an authorized clinician user of the client EHR during performance of a clinical subtask of a prescription ordering task.
GRANT
Utility
Drag and drop to highlight and transfer data
12 Oct 21
Electronic messages, such as emails, often ask questions, ask that a task be done, or assign a task.
GRANT
Utility
Database methodology for searching encrypted data records
21 Sep 21
A method for increasing sargability of encrypted records to allow for searching of a first column of a first data table for encrypted values containing a search string without having to decrypt all encrypted values involves, for each respective data record in the first data table, accessing an encrypted data value from the first column, decrypting the accessed encrypted data value, generating from the decrypted data value a respective plurality of substrings of various lengths, encrypting each substring of the respective plurality of substrings as an encrypted substring token, and storing each encrypted substring token in association with a reference value for lookup of a corresponding record in the first data table.
GRANT
Utility
Flexible encounter tracking systems and methods
14 Sep 21
Embodiments include a customizable encounter document whose contents are populated based on a template for the current patient, a template for all the user's patients, or a combination of templates.
GRANT
Utility
Computing system for redirecting refills on an electronic prescription
7 Sep 21
A computing system for redirecting electronic prescription refills is disclosed herein.